Alpha Tau Medical Ltd (DRTS) - Total Liabilities
Based on the latest financial reports, Alpha Tau Medical Ltd (DRTS) has total liabilities worth $27.11 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Alpha Tau Medical Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Alpha Tau Medical Ltd - Total Liabilities Trend (2019–2024)
This chart illustrates how Alpha Tau Medical Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Alpha Tau Medical Ltd asset portfolio.
Alpha Tau Medical Ltd Competitors by Total Liabilities
The table below lists competitors of Alpha Tau Medical Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Waga Energy SA
PA:WAGA
|
France | €273.17 Million |
|
Shenzhen Guangju Energy Co Ltd
SHE:000096
|
China | CN¥546.23 Million |
|
Grid Dynamics Holdings Inc
NASDAQ:GDYN
|
USA | $80.44 Million |
|
Svolder AB (publ)
ST:SVOL-B
|
Sweden | Skr109.50 Million |
|
India Tourism Development Corporation Limited
NSE:ITDC
|
India | Rs3.51 Billion |
|
SurModics Inc
NASDAQ:SRDX
|
USA | $58.51 Million |
|
CytomX Therapeutics Inc
NASDAQ:CTMX
|
USA | $79.16 Million |
|
MarineMax Inc
NYSE:HZO
|
USA | $1.48 Billion |
Liability Composition Analysis (2019–2024)
This chart breaks down Alpha Tau Medical Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See DRTS net asset quality score to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 8.43 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.35 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Alpha Tau Medical Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Alpha Tau Medical Ltd (2019–2024)
The table below shows the annual total liabilities of Alpha Tau Medical Ltd from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $23.54 Million | +2.73% |
| 2023-12-31 | $22.91 Million | +58.11% |
| 2022-12-31 | $14.49 Million | -81.18% |
| 2021-12-31 | $76.99 Million | +25.36% |
| 2020-12-31 | $61.42 Million | +93.44% |
| 2019-12-31 | $31.75 Million | -- |
About Alpha Tau Medical Ltd
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical or pending cl… Read more